The cartilage matrix molecule components produced by human foetal cartilage rudiment cells within scaffolds and the role of exogenous growth factors

Biomaterials

Volumn 33, Issue 16, 2012, Pages 4078-4088

  Chuang, Christine Y ^a   Shahin, Kifah ^a   Lord, Megan S ^a   Melrose, James ^b   Doran, Pauline M ^c   Whitelock, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Alginate; Cartilage scaffold; Chondrocytes; Extracellular matrix; Perlecan; Polyglycolic acid

Indexed keywords

CARTILAGE REPAIR; CELL PELLETS; CHONDROCYTES; CHONDROGENESIS; EXOGENOUS GROWTH; EXTRACELLULAR MATRICES; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HYALINE CARTILAGE; IN-VITRO; MATRIX COMPONENTS; MATRIX MOLECULES; PERLECAN; POLY GLYCOLIC ACID; POLYGLYCOLIC ACIDS; QUALITY OF LIFE; RESEARCH OBJECTIVES; SELF REPAIR; SOCIO-ECONOMIC IMPACTS; SODIUM ALGINATES; SYNTHETIC SCAFFOLDS; THREE-DIMENSIONAL SCAFFOLDS; TRAUMATIC INJURY; TYPE II COLLAGENS; TYPE X COLLAGEN; WEIGHT BEARING;

ALGINATE; BODY FLUIDS; CARTILAGE; CELL CULTURE; CELLS; COLLAGEN; MONOLAYERS; PELLETIZING; PEPTIDES; TISSUE;

SCAFFOLDS (BIOLOGY);

AGGRECAN; ALGINIC ACID; COLLAGEN TYPE 2; FIBROBLAST GROWTH FACTOR 18; FIBROBLAST GROWTH FACTOR 2; MOLECULAR SCAFFOLD; POLYGLYCOLIC ACID;

ARTICLE; CARTILAGE CELL; CARTILAGE MATRIX; CELL COMPONENT; CELL ELONGATION; CHONDROGENESIS; FETUS; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN FUNCTION; STEM CELL;

AGGRECANS; ALGINATES; CARTILAGE; CELLS, CULTURED; CHONDROGENESIS; COLLAGEN TYPE II; CULTURE MEDIA; EXTRACELLULAR MATRIX; FETUS; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTORS; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; IMMUNOHISTOCHEMISTRY; POLYGLYCOLIC ACID; STEM CELLS;

EID: 84858795816     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.032     Document Type: Article

References (53)

1. Brooks P.M. The burden of musculoskeletal disease. A global perspective. Clin Rheumatol 2006, 25:778-781.
2. Heinegard D., Saxne T. The role of the cartilage matrix in osteoarthritis. Nat Rev Rheumatol 2011, 7:50-56.
3. Batty L., Dance S., Bajaj S., Cole B.J. Autologous chondrocyte implantation: an overview of technique and outcomes. ANZ J Surg 2011, 81:18-25.
4. Moreira-Teixeira L.S., Georgi N., Leijten J., Wu L., Karperien M. Cartilage tissue engineering. Endocr Dev 2011, 21:102-115.
5. Darling E.M., Athanasiou K.A. Retaining zonal chondrocyte phenotype by means of novel growth environments. Tissue Eng 2005, 11:395-403.
6. Simon T.M., Jackson D.W. Articular cartilage: injury pathways and treatment options. Sports Med Arthrosc 2006, 14:146-154.
7. Gomes R.R., Farach-Carson M.C., Carson D.D. Perlecan functions in chondrogenesis: insights from in vitro and in vivo models. Cells Tissues Organs 2004, 176:79-86.
8. Yang W., Gomes R.R., Brown A.J., Burdett A.R., Alicknavitch M., Farach-Carson M.C., et al. Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenic protein-2-based matrices. Tissue Eng 2006, 12:2009-2024.
9. Munakata H., Takagaki K., Majima M., Endo M. Interaction between collagens and glycosaminoglycans investigated using a surface plasmon resonance biosensor. Glycobiology 1999, 9:1023-1027.
10. Kirn-Safran C.B., Gomes R.R., Brown A.J., Carson D.D. Heparan sulfate proteoglycans: coordinators of multiple signaling pathways during chondrogenesis. Birth Defects Res C Embryo Today 2004, 72:69-88.
11. Arikawa-Hirasawa E., Watanabe H., Takami H., Hassell J.R. Perlecan is essential for cartilage and cephalic development. Nat Genet 1999, 23:354-358.
12. Melrose J., Smith S., Knox S., Whitelock J. Perlecan, the multidomain HS-proteoglycan of basement membranes, is a prominent pericellular component of ovine hypertrophic vertebral growth plate and cartilaginous endplate chondrocytes. Histochem Cell Biol 2002, 118:269-280.
13. Weksler N.B., Lunstrum G.P., Reid E.S., Horton W.A. Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro. Biochem J 1999, 342:677-682.
14. Ohbayashi N., Shibayama M., Kurotaki Y., Imanishi M., Fujimori T., Itoh N., et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002, 16:870-879.
15. Melrose J., Chuang C., Whitelock J. Tissue engineering of cartilages using biomatrices. J Chem Tech Biotech 2008, 83:444-463.
16. Pieper J.S., van der Kraan P.M., Hafmans T., Kamp J., Buma P., van Susante J.L.C., et al. Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering. Biomaterials 2002, 23:3183-3192.
17. Grigolo B., Lisignoli G., Pascentini A., Fiorini M., Gobbi P., Mazzotti G., et al. Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAFF11): molecular, immunohistochemical and ultrastructural analysis. Biomaterials 2002, 23:1187-1195.
18. Tran-Khanh N., Chevrier A., Lascau-Coman V., Hoemann C.D., Buschmann M.D. Young adult chondrocytes proliferate rapidly and produce a cartilaginous tissue at the gel-media interface in agarose cultures. Conn Tissue Res 2010, 51:216-223.
19. Häuselmann H.J., Fernandes R.J., Mok S.S., Schmid T.M., Block J.A., Aydelotte M.B., et al. Phenotypic stability of bovine articular chondrocytes after long-term culture in alginate beads. J Cell Sci 1994, 107:17-27.
20. Ruggiero F., Petit B., Ronziere M.C., Farjanel J., Hartmann D.J., Herbage D. Composition and organization of the collagen network produced by fetal bovine chondrocytes cultured at high density. J Histochem Cytochem 1993, 41:867-875.
21. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998, 238:265-272.
22. Kobayashi M. A study of polyvinyl alcohol-hydrogel (PVA-H) artificial meniscus in vivo. Biomed Mater Eng 2004, 14:505-515.
23. Fisher J.P., Jo S., Mikos A.G., Reddi A.H. Thermo-reversible hydrogel scaffolds for articular cartilage engineering. J Biomed Mater Res A 2004, 7:268-274.
24. Rampichova M., Kostakova E., Filova E., Prosecka E., Plencner M., Ocheretna L., et al. Non-woven PGA/PVA fibrous mesh as an appropriate scaffold for chondrocyte proliferation. Physiol Res 2010, 59:773-781.
25. Shahin K., Doran P.M. Strategies for enhancing the accumulation and retention of extracellular matrix in tissue-engineered cartilage cultured in bioreactors. PLoS ONE 2001, art no. e23119.
26. Cao Y., Rodriguez A., Vacanti M., Ibarra C., Arevalo C., Vacanti C.A. A comparative study of the use of poly(glycolic acid), calcium alginate and pluronics in the engineering of autologous porcine cartilage. J Biomater Sci Polym Ed 1998, 9:475-487.
27. Freed L.E., Marquis J.C., Nohria A., Emmanual J., Moikos A.G., Langer R. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 2004, 27:11-23.
28. Larson C.M., Kelley S.S., Blackwood A.D., Banes A.J., Lee G.M. Retention of the native chondrocyte pericellular matrix results in significantly improved matrix production. Matrix Biol 2002, 21:349-359.
29. Melrose J., Smith S., Ghosh P. Histological and immunohistological studies on cartilage. Methods Mol Med 2004, 101:39-63.
30. Melrose J., Smith S., Cake M., Read R., Whitelock J. Spatial and temporal immunolocalisation of perlecan in the ovine meniscus. Histochem Cell Biol 2005, 124:225-235.
31. Smith S.M., Shu C., Melrose J. Comparative immunolocalisation of perlecan with collagen II and aggrecan in human foetal, newborn and adult ovine joint tissues demonstrates perlecan as an early developmental chondrogenic marker. Histochem Cell Biol 2010, 134:251-263.
32. West L., Govindraj P., Koob T.J., Hassell J.R. Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate. J Orthop Res 2006, 24:1317-1326.
33. Whitelock J.M., Melrose J., Iozzo R.V. Diverse cell signaling events modulated by perlecan. Biochemistry 2008, 47:11174-11183.
34. Melrose J., Hayes A.J., Whitelock J.M., Little C.B. Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues. Bioessays 2008, 30:457-469.
35. Chuang C.Y., Lord M.S., Melrose J., Rees M.D., Knox S.M., Freeman C., et al. Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan. Biochemistry 2010, 49:5524-5532.
36. Govindraj P., West L., Koob T.J., Neame P., Doego K., Hassell J.R. Isolation and identification of the major heparan sulfate proteoglycans in the developing bovine rib growth plate. J Biol Chem 2002, 277:19461-19469.
37. SundarRaj N., Fite D., Ledbetter S., Chakravarti S., Hassell J.R. Perlecan is a component of cartilage matrix and promotes chondrocyte attachment. J Cell Sci 1995, 108:2663-2672.
38. Smith S.M., West L.A., Govindraj P., Zhang X., Ornitz D.M., Hassell J.R. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors. Matrix Biol 2007, 26:175-184.
39. Patil A.S., Sable R.B., Kothari R.M. Occurence, biochemical profile of vascular endothelial growth factor (VEGF) isoforms and their functions in endochondral ossification. J Cell Physiol 2012, 227:1298-1308.
40. Kvist A.J., Johnson A.E., Mörgelin M., Gustafsson E., Bengtsson E., Lindblom K., et al. Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias. J Biol Chem 2006, 281:33127-33139.
41. Rapp A., Brandl N., Huettinger M. Evaluation of chondroitin sulfate bioactivity in hippocampal neurones and the astrocyte cell line U373: influence of position of sulfate groups and charge density. Basic Clin Pharmacol Toxicol 2005, 96:37-43.
42. Vincent T.L., McLean C.J., Full L.E., Peston D., Saklatvala J. FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthritis Cartilage 2007, 15:752-763.
43. Zhang L., Su P., Xu C., Yang J., Yu W., Huang D. Chondrogenic differentiation of human mesenchymal stem cells: a comparison between micromass and pellet culture systems. Biotechnol Lett 2010, 32:1339-1346.
44. Schrobback K., Klein T.J., Schuetz M., Upton Z., Leavesley D.I., Malda J. Adult human articular chondrocytes in a microcarrier-based culture system: expansion and redifferentiation. J Orthop Res 2011, 29:539-546.
45. Kang S.-W., Yoo S.P., Kim B.-S. Effect of chondrocyte passage number on histological aspects of tissue-engineered cartilage. Biomed Mater Eng 2007, 17:269-276.
46. Lin Z., Fitzgerald J.B., Xu J., Willers C., Wood D., Grodzinsky A.J., et al. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res 2008, 26:1230-1237.
47. Shimazu A., Nah H.D., Kirsch T., Koyama E., Leatherman J.L., Golden E.B., et al. Syndecan-3 and the control of chondrocyte proliferation during endochondral ossification. Exp Cell Res 1996, 229:126-136.
48. Pufe T., Petersen W.J., Miosge N., Goldring M.B., Mentlein R., Varoga D.J., et al. Endostatin/collagen XVIII - an inhibitor of angiogenesis-is expressed in cartilage and fibrocartilage. Matrix Biol 2004, 23:267-276.
49. Andrade L.R., Arcanjo K.D.S., Martins S.H.L., dos Reis J.S.N., Borojevic R., Duarte M.E.L. Fine structure and molecular content of human chondrocytes encapsulated in alginate beads. Cell Biol Int 2001, 35:293-297.
50. Chia S.L., Sawaji Y., Burleigh A., McLean C., Inglis J., Saklatvala J., et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 2009, 60:2019-2027.
51. Krejci P., Krakow D., Mekikian P.B., Wilcox W.R. Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligands expressed in human fetal growth plate cartilage. Pediatr Res 2007, 61:267-272.
52. Davidson D., Blacnc A., Filion D., Wang H., Plut P., Gfeffer G., et al. Fibroblast growth factor (FGF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Cell Biochem 2005, 97:33-44.
53. Liu Z., Lavine K.J., Hung I.H., Ornitz D.M. FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev Biol 2007, 302:80-91.